93.84
+1.58
+(1.71%)
At close: January 31 at 10:00:18 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 21 | 10 | 28 | 28 |
| Avg. Estimate | 7.15B | 6.66B | 28.3B | 28.42B |
| Low Estimate | 6.8B | 6.44B | 28B | 27.06B |
| High Estimate | 7.49B | 6.9B | 28.67B | 29.64B |
| Year Ago Sales | 7.12B | 6.69B | 27.12B | 28.3B |
| Sales Growth (year/est) | 0.45% | -0.38% | 4.38% | 0.43% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1GILD.MI | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 1/29/2025 |
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 1/10/2025 |
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 12/11/2024 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 12/11/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 12/10/2024 |
| Maintains | UBS: Neutral to Neutral | 11/21/2024 |